Skip to main content
. Author manuscript; available in PMC: 2018 Mar 30.
Published in final edited form as: Ann Intern Med. 2017 Aug 22;167(6):384–393. doi: 10.7326/M17-0520

FIGURE 1. STUDY FLOW DIAGRAM.

FIGURE 1

Legend: MVC, maraviroc; FTC, emtricitabine; TDF, tenofovir disoproxil fumarate. * Two participants were randomized, but never started their study regimen (one randomized to MVC alone who refused further participation and one to MVC+FTC who was unable to be contacted).